Lin Feng
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Co-authors
- Kaitai ZhangShujun ChengXuebing DiTing XiaoWen ZhangJianzhong ShouLiping GuoBingqing Shang
- Topics
- RNA modifications and cancer (17 papers)Cancer Immunotherapy and Biomarkers (14 papers)Cancer-related molecular mechanisms research (13 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Lin Feng
70 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 560
- Cancer Research 401
- Oncology 399
- Pulmonary and Respiratory Medicine 328
- Immunology 313
Countries citing papers authored by Lin Feng
This map shows the geographic impact of Lin Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Feng more than expected).
Fields of papers citing papers by Lin Feng
This network shows the impact of papers produced by Lin Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Feng. The network helps show where Lin Feng may publish in the future.
Co-authorship network of co-authors of Lin Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Lin Feng. A scholar is included among the top collaborators of Lin Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Feng. Lin Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 21 | |
| 11 | 133 | |
| 12 | 6 | |
| 13 | 19 | |
| 14 | 11 | |
| 15 | 5 | |
| 16 | 5 | |
| 17 | 24 | |
| 18 | 12 | |
| 19 | 24 | |
| 20 | 74 |
About Lin Feng
Lin Feng is a scholar working on Cancer Research, Oncology and Immunology, having authored 76 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (17 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Cancer-related molecular mechanisms research (13 papers). The work is most often cited by research in Cancer Research (401 citations), Immunology (313 citations) and Oncology (399 citations). Lin Feng has collaborated with scholars based in China, United States and India. Frequent co-authors include Kaitai Zhang, Shujun Cheng, Xuebing Di, Ting Xiao, Shujun Cheng, Wen Zhang, Jianzhong Shou, Liping Guo, Bingqing Shang and Yi Zhang. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.